EMAIL THIS PAGE TO A FRIEND

Journal of immunology (Baltimore, Md. : 1950)

Programmed death-1 impairs secondary effector lung CD8⁺ T cells during respiratory virus reinfection.


PMID 25339663

Abstract

Reinfections with respiratory viruses are common and cause significant clinical illness, yet precise mechanisms governing this susceptibility are ill defined. Lung Ag-specific CD8(+) T cells (T(CD8)) are impaired during acute viral lower respiratory infection by the inhibitory receptor programmed death-1 (PD-1). To determine whether PD-1 contributes to recurrent infection, we first established a model of reinfection by challenging B cell-deficient mice with human metapneumovirus (HMPV) several weeks after primary infection, and found that HMPV replicated to high titers in the lungs. A robust secondary effector lung TCD8 response was generated during reinfection, but these cells were more impaired and more highly expressed the inhibitory receptors PD-1, LAG-3, and 2B4 than primary T(CD8). In vitro blockade demonstrated that PD-1 was the dominant inhibitory receptor early after reinfection. In vivo therapeutic PD-1 blockade during HMPV reinfection restored lung T(CD8) effector functions (i.e., degranulation and cytokine production) and enhanced viral clearance. PD-1 also limited the protective efficacy of HMPV epitope-specific peptide vaccination and impaired lung T(CD8) during heterotypic influenza virus challenge infection. Our results indicate that PD-1 signaling may contribute to respiratory virus reinfection and evasion of vaccine-elicited immune responses. These results have important implications for the design of effective vaccines against respiratory viruses.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1405591
Anti-CD48 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB2103930
Anti-HAVCR2, (N-terminal) antibody produced in rabbit, affinity isolated antibody
HPA013967
Anti-LAG3 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1401228
Anti-LAG3 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
PRS4065
Anti-PD-1 (ab1) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
PRS4067
Anti-PD-1 (ab2) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2900280
Anti-PDCD1 (AB1) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2900373
Anti-PDCD1 (AB2) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2500763
Anti-PDCD1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1400196
Anti-PDCD1 antibody produced in mouse, IgG fraction of antiserum, buffered aqueous solution
HPA035981
Anti-PDCD1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA013411 Anti-PDCD1LG2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1411458
Anti-PDCD1LG2 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
WH0000962M1
Monoclonal Anti-CD48 antibody produced in mouse, clone 3B8-2C2, purified immunoglobulin, buffered aqueous solution
SAB4700192 Monoclonal Anti-CD48 antibody produced in mouse, clone MEM-102, purified immunoglobulin, buffered aqueous solution
SAB3500122
Monoclonal Anti-PD-1 antibody produced in mouse, clone 7A11B1, purified immunoglobulin, buffered aqueous solution
SAB3500123
Monoclonal Anti-PD-1 antibody produced in mouse, clone 12A7D7, purified immunoglobulin, buffered aqueous solution